Letter to the Editor
On “A Comprehensive Review of COVID-19–Associated Endocrine Manifestation”
Abstract
To the Editor: The article “A Comprehensive Review of COVID-19–Associated Endocrine Manifestation” by Khan et al delivered a concise and informative overview of the effect of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection on the endocrine systems.1This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Khan S, Karim M, Gupta V, et al. A comprehensive review of COVID-19– associated endocrine manifestations. South Med J 2023;116:350–354.
2. Clarke SA, Abbara A, Dhillo WS. Impact of COVID-19 on the endocrine system: a minireview. Endocrinology 2022;163:bqab203.
3. Bansal R, Gubbi S, Koch CA. COVID-19 and chronic fatigue syndrome: an endocrine perspective. J Clin Transl Endocrinol 2022;27; 100284.
4. Soldevila B, Puig-Domingo M, Marazuela M. Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated? Rev Endocr Metab Disord 2022;23:137–150.
5. Bornstein SR, Cozma D, Kamel M, et al. LongCOVID, Metabolic and endocrine disease. Horm Metab Res 2022;54:562–566.
